These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26957610)

  • 21. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours.
    Oberg K
    Ann Oncol; 2001; 12 Suppl 2():S111-4. PubMed ID: 11762335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin analogues do not prevent carcinoid crisis.
    Guo LJ; Tang CW
    Asian Pac J Cancer Prev; 2014; 15(16):6679-83. PubMed ID: 25169508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cases in the Management of NETs: Focus on Sequencing Somatostatin Analogs.
    Iyer R
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):4-7. PubMed ID: 27167991
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent advances in carcinoid pathogenesis, diagnosis and management.
    Ganim RB; Norton JA
    Surg Oncol; 2000 Dec; 9(4):173-9. PubMed ID: 11476988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-acting somatostatin analogues in the treatment of unresectable/metastatic neuroendocrine tumors.
    Enzler T; Fojo T
    Semin Oncol; 2017 Apr; 44(2):141-156. PubMed ID: 28923213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin analogs in acromegaly.
    Freda PU
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3013-8. PubMed ID: 12107192
    [No Abstract]   [Full Text] [Related]  

  • 27. [Application of preparations--analogues of somatostatin in surgical pancreatology].
    Kopchak VM; Kostylev MV; Kopchak KV; Egorova ON; Khomiak IV; Duvalko AV; Romaniv IaV; Pererva LA
    Klin Khir; 2008 Jan; (1):18-21. PubMed ID: 18610850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-acting formulations of somatostatin analogues.
    Anthony LB
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S216-8. PubMed ID: 10604134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours.
    Aparicio T; Ducreux M; Baudin E; Sabourin JC; De Baere T; Mitry E; Schlumberger M; Rougier P
    Eur J Cancer; 2001 May; 37(8):1014-9. PubMed ID: 11334727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
    Janson ET; Oberg K
    Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
    [No Abstract]   [Full Text] [Related]  

  • 31. Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease.
    Krassas GE; Doumas A; Kaltsas T; Halkias A; Pontikides N
    Thyroid; 1999 Jan; 9(1):47-52. PubMed ID: 10037076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-alpha versus somatostatin or the combination of both in metastatic neuroendocrine gut and pancreatic tumours.
    Faiss S; Scherübl H; Riecken EO; Wiedenmann B
    Digestion; 1996; 57 Suppl 1():84-5. PubMed ID: 8813478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Somatostatin Analogues in Oncology. European Neuroendocrine Tumor Network (ENET). February 24-27, 2000, Innsbruck, Austria. Proceedings.
    Digestion; 2000; 62 Suppl 1():1-108. PubMed ID: 11001649
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review.
    Arnold R; Simon B; Wied M
    Digestion; 2000; 62 Suppl 1():84-91. PubMed ID: 10940693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slow-release lanreotide and octreotide LAR in the medical therapy of acromegaly.
    Giusti M; Sessarego P; Timossi G; Bocca L
    Eur J Endocrinol; 2000 Jun; 142(6):697-8. PubMed ID: 10822235
    [No Abstract]   [Full Text] [Related]  

  • 36. The clinical management of neuroendocrine tumors with long-acting repeatable (LAR) octreotide: comparison with standard subcutaneous octreotide therapy.
    Dogliotti L; Tampellini M; Stivanello M; Gorzegno G; Fabiani L
    Ann Oncol; 2001; 12 Suppl 2():S105-9. PubMed ID: 11762334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of somatostatin analogues in the treatment of neuroendocrine tumors.
    Narayanan S; Kunz PL
    J Natl Compr Canc Netw; 2015 Jan; 13(1):109-17; quiz 117. PubMed ID: 25583773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current treatment of carcinoid tumor].
    Elizalde I; Borda F
    Gastroenterol Hepatol; 2002 Oct; 25(8):508-13. PubMed ID: 12361534
    [No Abstract]   [Full Text] [Related]  

  • 39. Carcinoid of the pancreas.
    Migliori M; Tomassetti P; Lalli S; Casadei R; Santini D; Corinaldesi R; Gullo L
    Pancreatology; 2002; 2(2):163-6. PubMed ID: 12123097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoid crisis induced by repeated abdominal examination.
    Morrisroe K; Sim IW; McLachlan K; Inder WJ
    Intern Med J; 2012 Mar; 42(3):342-4. PubMed ID: 22432991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.